Scarica l'app Stockscreener
3.07
2.23%
-0.07
Precedente Chiudi:
$3.14
Aprire:
$3.15
Volume 24 ore:
1.28M
Relative Volume:
0.65
Capitalizzazione di mercato:
$4.56M
Reddito:
-
Utile/perdita netta:
$-6.64M
Rapporto P/E:
-0.0171
EPS:
-179.3009
Flusso di cassa netto:
$-5.60M
1 W Prestazione:
-8.08%
1M Prestazione:
-19.23%
6M Prestazione:
-88.24%
1 anno Prestazione:
-99.11%
Intervallo 1D:
$2.94
$3.44
Intervallo di 1 settimana:
$2.92
$3.55
Portata 52W:
$2.10
$524.00
Clearmind Medicine Inc Stock (CMND) Company Profile
Nome
Clearmind Medicine Inc
Settore
Industria
Telefono
-
Indirizzo
-
Compare CMND vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
3.07 | 4.56M | 0 | -6.64M | -5.60M | -179.30 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Clearmind Medicine Inc Borsa (CMND) Ultime notizie
HRT Financial LP trims Clearmind Medicine (CMND) stake with 22,139-share sale - Stock Titan
Clearmind Medicine receives U.S. patent for binge behavior treatment - Investing.com
Clearmind Medicine Inc Share PriceCMND, RNS News, Articles, Quotes, & Charts (NASDAQ:CMND) - Proactive financial news
symbol__ Stock Quote Price and Forecast - CNN
Insider Sell: Financial Hrt Reduces Stake in Clearmind Medicine Inc (CMND) - GuruFocus
Clearmind Medicine Inc (CMND) Institutional Confidence - TradingKey
Clearmind Medicine (CMND) holder HRT Financial LP sells 3,183 shares - Stock Titan
Clearmind Medicine Inc (CMND) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clearmind Medicine Inc (CMND) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Clearmind Medicine Inc (CMND) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clearmind Medicine Inc (CMND) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clearmind Medicine Inc (CMND) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clearmind completes dosing for phase I/II alcohol disorder trial By Investing.com - Investing.com South Africa
Clearmind Medicine finishes dosing 24 trial participants - grafa.com
HRT Financial LP trims Clearmind Medicine (CMND) stake with 2,102-share sale - Stock Titan
Clearmind Medicine Completes Dosing For Part A Of Its Of FDA-Regulated Phase I/Ii Clinical Trial - TradingView
Experimental alcohol addiction drug completes first-stage testing - Stock Titan
Clearmind Medicine Inc (CMND) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Cash per share of Clearmind Medicine Inc. – FWB:CWY0 - TradingView
Tangible book value per share of Clearmind Medicine Inc. – FWB:CWY0 - TradingView
Clearmind Medicine Jumps 24.1% as Traders React to Fresh CMND-100 Updates and Upcoming June 10 Webinar - Moomoo
Clearmind Medicine Company Profile & Introduction - Moomoo
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Clearmind Medicine Inc. - MLQ.ai
Clearmind Medicine jumps 24.1% as traders react to fresh CMND-100 updates and upcoming June 10 webinar - Quiver Quantitative
CMND Stock Jumps As Clearmind Wins Key Trial, IP Milestones - StocksToTrade
CMND Stock Jumps As Clearmind Advances Trials And Expands IP - timothysykes.com
$Clearmind Medicine (CMND.US)$ - Moomoo
Clearmind Medicine to Present CMND-100 Clinical Trial Data on June 5, 2026 - geneonline.com
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on 'Inside MEAI” Webinar - The Manila Times
Clearmind Medicine Inc. to Host Live Webinar on MEAI and Alcohol Use Disorder with Yale and Johns Hopkins on June 10, 2026 - Quiver Quantitative
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar - marketscreener.com
Clearmind Medicine Shares On The Move With Cash Question Looming - Bez Kabli
CMND News | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Why Did CMND Stock Jump 40% Today? - Stocktwits
CMND Technical Analysis | Trend, Signals & Chart Patterns | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Why Taylor Morrison Home Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Sahm
Clearmind Medicine (CMND) Revenue BreakdownMain Composition - Moomoo
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Clearmind announces Japanese patent application for MEAI depression treatment By Investing.com - Investing.com South Africa
Clearmind announces Japanese patent application for MEAI depression treatment - Investing.com UK
CMND Stock Jumps As Clearmind Advances Trials And IP Push - StocksToTrade
CMND Stock Spikes As Clearmind Advances Johns Hopkins Trial - timothysykes.com
Clearmind Medicine stock surges 95% on Japan patent filing By Investing.com - Investing.com Canada
Clearmind Medicine stock surges 95% on Japan patent filing - Investing.com
Clearmind Medicine Inc. Announces Publication of Japanese Patent Application for MEAI in Depression Treatment - Quiver Quantitative
Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment - The Manila Times
Clearmind Medicine(CMND) Stock Options Chain | Quotes & News - Moomoo
CMND Stock Price, Quote & Chart | CLEARMIND MEDICINE INC (NASDAQ:CMND) - ChartMill
Clearmind Medicine announces JHM-IRB approval to advance CMND-100 trial - TipRanks
Clearmind receives Johns Hopkins IRB approval for trial parts - Investing.com UK
Clearmind Medicine Inc Azioni (CMND) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):